Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009

JAMA

Volumn 307, Issue 18, 2012, Pages 1934-1940

  Patrick, Stephen W ^a   Schumacher, Robert E ^a   Benneyworth, Brian D ^a   Krans, Elizabeth E ^b   McAllister, Jennifer M ^a   Davis, Matthew M ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD HEALTH; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEEDING DISORDER; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; INFANT; LENGTH OF STAY; LIVE BIRTH; LOW BIRTH WEIGHT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEWBORN; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEIZURE; TREND STUDY; WITHDRAWAL SYNDROME;

EID: 84860776122     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.3951     Document Type: Article

References (45)

1. Substance Abuse and Mental Health Administration. Office of Applied Studies, Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
2. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006; 160(2):173-176. (Pubitemid 43213863)
3. Pierog S, Chandavasu O, Wexler I. Withdrawal symptoms in infants with the fetal alcohol syndrome. J Pediatr. 1977;90(4):630-633. (Pubitemid 8083192)
4. Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med. 2005;159(9):824-834. (Pubitemid 41248389)
5. Rementería JL, Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr. 1977;90(1):123-126. (Pubitemid 8015653)
6. Hulse GK, Milne E, English DR, Holman CDJ. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997; 92(11):1571-1579. (Pubitemid 27499568)
7. Madden JD, Chappel JN, Zuspan F, Gumpel J, Mejia A, Davis R. Observation and treatment of neonatal narcotic withdrawal. Am J Obstet Gynecol. 1977; 127(2):199-201. (Pubitemid 8032999)
8. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG. 2009;116(5):665-671.
9. Minozzi S, Amato L, Vecchi S, Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev. 2008; (2):CD006318.
10. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics. 1998; 101(6):1079-1088.
11. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr. 1991;118(6):933-937.
12. O'Donnell M, Nassar N, Leonard H, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics. 2009;123(4):e614-e621.
13. Overview of the Kids' Inpatient Database (KID). Healthcare Cost and Utilization Project (HCUP): 2000, 2003, 2006, 2009. http://www.hcup-us.ahrq.gov /kidoverview.jsp. Accessed April 6, 2012.
14. Benneyworth BD, Gebremariam A, Clark SJ, Shanley TP, Davis MM. Inpatient health care utilization for children dependent on long-term mechanical ventilation. Pediatrics. 2011;127(6):e1533-e1541.
15. Zickafoose JS, Benneyworth BD, Riebschleger MP, Espinosa CM, Davis MM. Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolesc Med. 2012;166(4):350-355.
16. Myrvik MP, Campbell AD, Davis MM, Butcher JL. Impact of psychiatric diagnoses on hospital length of stay in children with sickle cell anemia. Pediatr Blood Cancer. 2012;58(2):239-243.
17. Macy ML, Stanley RM, Sasson C, Gebremariam A, Davis MM. High turnover stays for pediatric asthma in the United States: analysis of the 2006 Kids' Inpatient Database. Med Care. 2010;48(9):827-833.
18. Odetola FO, Gebremariam A, Davis MM. Comorbid illnesses among critically ill hospitalized children: impact on hospital resource use and mortality, 1997-2006. Pediatr Crit Care Med. 2010;11(4): 457-463.
19. Healthcare Cost and Utilization Project (HCUP). Introduction to the KID: 2009, HCUP KID Related Reports. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
20. Overview of the Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP): 2007-2009. http://www.hcup-us.ahrq.gov /nisoverview.jsp. Accessed April 6, 2012.
21. Healthcare Cost and Utilization Project (HCUP). Introduction to the NIS: 2009, HCUP NIS Related Reports. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
22. Kandall SR, Albin S, Lowinson J, Berle B, Eidelman AI, Gartner LM. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics. 1976; 58(5):681-685.
23. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis an categorical variables. Stata Journal. 2009;9(3):466-477.
24. US Bureau of Labor Statistics. 2010 Consumer Price Index. http://www.bls.gov/cpi/. Accessed April 6, 2012.
25. Weisberg S. Applied linear regression. 3rd ed. In: Wiley Series in Probability and Statistics. Hoboken, NJ: Wiley-Interscience; 2005.
26. Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol. 2011;204(3): 259.e1-259.e4.
27. Signs V; Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb Mortal Wkly Rep. 2011;60(43): 1487-1492.
28. Centers for Disease Control and Prevention (CDC). Drug overdose deaths - Florida, 2003-2009. MMWR Morb Mortal Wkly Rep. 2011;60(26):869-872.
29. Prescription Drug Abuse. CS/CS/HB 227 (Fla 2012). http://www. myfloridahouse.gov/Sections /Bills/billsdetail.aspx?BillId=47335. Accessed April 6, 2012.
30. US General Accounting Office. Drug-Exposed Infants: A Generation at Risk. Washington, DC: US General Accounting Office; 1990.
31. Backes CH, Backes CR, Gardner D, Nankervis CA, Giannone PJ, Cordero L. Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting. J Perinatol. 2011. doi:10.1038/jp.2011.114.
32. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug Alcohol Rev. 2007;26 (5):487-492.
33. Agthe AG, Kim GR, Mathias KB, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009;123(5):e849-e856.
34. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am. 1998;25(1):139-151. (Pubitemid 28141705)
35. Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008;17(5):372-386.
36. Almario CV, Seligman NS, Dysart KC, Berghella V, Baxter JK. Risk factors for preterm birth among opiate-addicted gravid women in amethadone treatment program. Am J Obstet Gynecol. 2009;201 (3):326.e1-326.e6.
37. Brown HL, Britton KA, Mahaffey D, Brizendine E, Hiett AK, Turnquest MA. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol. 1998;179(2):459-463. (Pubitemid 28413384)
38. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320-2331.
39. Arlettaz R, Kashiwagi M, Das-Kundu S, Fauchère JC, Lang A, Bucher HU. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand. 2005;84(2):145-150. (Pubitemid 40278802)
40. Osborn DA, Jeffery HE, Cole MJ. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;(10):CD002053.
41. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol. 2006;26(1):15-17. (Pubitemid 43135249)
42. Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr. 2002;140(5):561-564. (Pubitemid 34666726)
43. Jansson LM, Velez M, Harrow C. Methadone maintenance and lactation: a review of the literature and current management guidelines. J Hum Lact. 2004; 20(1):62-71. (Pubitemid 39199229)
44. Wachman EM, Byun J, Philipp BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med. 2010;5(4):159-164.
45. Saiki T, Lee S, Hannam S, Greenough A. Neonatal abstinence syndrome: postnatal ward versus neonatal unit management. Eur J Pediatr. 2010;169 (1):95-98.